Last week, Drug Dealer Simulator launched on Xbox for the first time, but the big news wasn't about it's new platform, it was about the controversy surrounding it and Schedule I, a game that’s taken the Steam charts by storm.
While Schedule I continues to gain massive traction, topping sales and player counts, the developers of Drug Dealer Simulator, Byterunners, have found themselves caught in a messy situation they didn’t ask for.
Despite being review-bombed by Schedule I fans, the team has been clear that they don't feel personally harmed by the success of Schedule I — and certainly not by the idea that their game has inspired it.
The accusations of intellectual property infringement are not being pursued by Byterunners themselves, but by their publisher, Movie Games S.A., who is legally required to investigate such matters as a publicly traded company.
